Bruno Corrêa Bellagamba

Bruno Corrêa Bellagamba

Auto-generated profile, based on publicly available information

Bruno Corrêa Bellagamba

Post-Graduation Program in Molecular and Cellular Biology Applied to Health, Lutheran University of Brazil (ULBRA), Canoas, RS, Brazil

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2016 in Genetics and Molecular Biology
Verified
Journal Article
Open access
BBBruno Corrêa Bellagamba
Bruno Corrêa Bellagamba
BABianca Regina Ribas de Abreu
Bianca Regina Ribas de Abreu
IGIvana Grivicich
Ivana Grivicich
CMCarolina Franke Markarian
Carolina Franke Markarian
ECEduardo Chem
Eduardo Chem
RDRafael Rodrigues Dihl
Rafael Rodrigues Dihl
Mesenchymal stem cells (MSCs) are known for their important properties involving multilineage differentiation potential., trophic factor secretion and localization along various organs and tissues. On the dark side, MSCs play a distinguished role in tumor microenvironments by differentiating into tumor-associated fibroblasts or supporting tumor growth via distinct mechanisms. Cisplatin (CIS) is a drug widely applied in the treatment of a large number of cancers and is known for its cytotoxic and genotoxic effects, both in vitro and in vivo. Here we assessed the effects of CIS on MSCs and the ovarian cancer cell line OVCAR-3, by MTT and comet assays. Our results demonstrated the resistance of MSCs to cell death and DNA damage induction by CIS, which was not observed when OVCAR-3 cells were exposed to this drug.

4 October 2011 in Stem Cells and Development
Verified
Journal Article
Closed access
CNClaudia Concer Viero Nora
Claudia Concer Viero Nora
MCMelissa Camassola
Melissa Camassola
BBBruno Bellagamba
Bruno Bellagamba
NINilo Ikuta
Nilo Ikuta
ACAna Christoff
Ana Christoff
NNNance Nardi
Nance Nardi
Mesenchymal stem cells (MSCs) have received great attention due to their remarkable regenerative, angiogenic, antiapoptotic, and immunosuppressive properties. Although conventionally isolated from the bone marrow, they are known to exist in all tissues and organs, raising the question on whether they are identical cell populations or have important differences at the molecular level. To better understand the relationship between MSCs residing in different tissues, we analyzed the expression of genes related to pluripotency (SOX2 and OCT-4) and to adipogenic (C/EBP and ADIPOR1), osteogenic (OMD and ALP), and chondrogenic (COL10A1 and TRPV4) differentiation in cultures derived from murine endodermal (lung) and mesodermal (adipose) tissue maintained in different conditions. MSCs were isolated from lungs (L-MSCs) and inguinal adipose tissue (A-MSCs) and cultured in normal conditions, in overconfluence or in inductive medium for osteogenic, adipogenic, or chondrogenic differentiation. Cultures were characterized for morphology, immunophenotype, and by quantitative real-time reverse transcription–polymerase chain reaction for expression of pluripotency genes or markers of differentiation. Bone marrow–derived MSCs were also analyzed for comparison of these parameters. L-MSCs and A-MSCs exhibited the typical morphology, immunophenotype, and proliferation and differentiation pattern of MSCs. The analysis of gene expression showed a higher potential of adipose tissue–derived MSCs toward the osteogenic pathway and of lung-derived MSCs to chondrogenic differentiation, representing an important contribution for the definition of the type of cell to be used in clinical trials of cell therapy and tissue engineering.

1 November 2010 in Food and Chemical Toxicology
Verified
Journal Article
Closed access
CDCristiane Cademartori Danesi
Cristiane Cademartori Danesi
BBBruno Corrêa Bellagamba
Bruno Corrêa Bellagamba
RDRafael Rodrigues Dihl
Rafael Rodrigues Dihl
HAHeloísa Helena Rodrigues de Andrade
Heloísa Helena Rodrigues de Andrade
KCKênya Silva Cunha
Kênya Silva Cunha
MLMauricio Lehmann
Mauricio Lehmann

1 April 2017 in Chemosphere
Verified
Journal Article
Closed access
CPCynthia Silva Porta
Cynthia Silva Porta
DSDébora Lemes dos Santos
Débora Lemes dos Santos
HBHélio Vieira Bernardes
Hélio Vieira Bernardes
BBBruno Corrêa Bellagamba
Bruno Corrêa Bellagamba
ADAnaí Duarte
Anaí Duarte
RDRafael Rodrigues Dihl
Rafael Rodrigues Dihl

1 February 2010 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
CDCristiane Cademartori Danesi
Cristiane Cademartori Danesi
BBBruno Corrêa Bellagamba
Bruno Corrêa Bellagamba
RDRafael Rodrigues Dihl
Rafael Rodrigues Dihl
HAHeloísa Helena Rodrigues de Andrade
Heloísa Helena Rodrigues de Andrade
KCKênya Silva Cunha
Kênya Silva Cunha
MLMauricio Lehmann
Mauricio Lehmann

1 September 2012 in Mutation Research - Genetic Toxicology and Environmental Mutagenesis
Verified
Journal Article
Closed access
CDCristiane Cademartori Danesi
Cristiane Cademartori Danesi
RDRafael Rodrigues Dihl
Rafael Rodrigues Dihl
BBBruno Corrêa Bellagamba
Bruno Corrêa Bellagamba
HAHeloísa Helena Rodrigues de Andrade
Heloísa Helena Rodrigues de Andrade
KCKênya Silva Cunha
Kênya Silva Cunha
MLMauricio Lehmann
Mauricio Lehmann